ArticleLeukemia & lymphoma2023

Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG.

Megan Othus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.